Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Moderna expects to start late-stage COVID-19 vaccine trial on July 27
Currently have 7 COVID 19 STOCKS
DVAX
MRNA
NVAX
VXRT
IBIO
SRNR
BCRX
Looking for 3 more !
Currently have 7 COVID 19 STOCKS
DVAX
MRNA
NVAX
VXRT
IBIO
SRNR
BCRX
Looking for 3 more !
THANKS
Currently have 6 COVID 19 STOCKS
DVAX
MRNA
NVAX
VXRT
IBIO
SRNR
Looking for 4 more !
Currently have 6 COVID 19 STOCKS
DVAX
MRNA
NVAX
VXRT
IBIO
SRNR
Looking for 4 more !
thanks
Currently have 4 COVID 19 STOCKS
DVAX
MRNA
NVAX
VXRT
Looking for 6 more !
MIGHT BE GOOD BUY.
EPS = -2.18
Float = 108 M
Market Cap = $ 955.23M
Good chance to make money.
EPS= -1.54
REV = 60 M
Market Cap=26 B
FLOAT = .3 B
Interesing !
Where Vaxart is unique is that they are working on a coronavirus vaccine in oral tablet form. Having a pill everyone can take is going to shut down this outbreak faster than the traditional shot in the arm method. Vaxart has initiated a program to develop a coronavirus vaccine candidate based on its proprietary oral vaccine platform, VAAST.
Might be a good trade. imho
RPS = -.79
REV = 9.66 M
In this case, B. Riley FBR appears to be very optimistic about the prospects for Vaxart's oral COVID-19 vaccine candidate. This experimental vaccine was recently selected by the U.S. government's Operation Warp Speed for funding and inclusion in a preclinical study
IBIO is a long shot for COVID 19 vaccine
EPS = -0.94
Revenue = $ 2.02M
Market Cap =$ 265.95M
A Phase 3 trial can be a pivotal moment. It is typically used to test the effectiveness of a vaccine in humans. It can also be used to confirm results from Phase 1 and 2 vaccine trials in a larger sample size.
Have given up posting on this board.
Good luck to all.
Buy type 1
Buy below 15 MA
To become part of the SP500
The sum of its previous four quarters of net income must be positive, with the most recent quarter also showing positive net income.
CGC never had a positive quarter.
Sounds like all you have is HYPE !
when do see warnings ?
Are you just guessing ?
Do you have estimated earnings ?
When you think about it this is a very high risk stock To buy now